ORBIMED ADVISORS LLC Insider Trading $ADAP Adaptimmune Therapeutics PLC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).

ORBIMED ADVISORS LLC in Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 4,902,910 shares
Current Value: $22,210,182
Latest Transaction: Jun 06 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Adaptimmune Therapeutics PLC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 06 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.491,60021,5844,901,3104.9 M to 4.9 M (-0.03 %)
Jun 06 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.5717,100232,0474,902,9104.9 M to 4.9 M (-0.35 %)
Jun 01 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.4950,000674,5004,920,0105 M to 4.9 M (-1.01 %)
Jun 01 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.52121,0001,635,9204,970,0105.1 M to 5 M (-2.38 %)
May 16 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.5010,300139,0505,091,0105.1 M to 5.1 M (-0.20 %)
Mar 29 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS11.5331,983368,7645,101,3105.1 M to 5.1 M (-0.62 %)
Mar 29 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS11.501,016,08411,684,9665,133,2936.1 M to 5.1 M (-16.52 %)
Mar 28 2017ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP4.201,190,4764,999,9996,149,3775 M to 6.1 M (+24.01 %)
May 25 2016ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP10.48518,4005,432,83229,753,40429.2 M to 29.8 M (+1.77 %)
May 25 2016ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP10.401,191,60012,392,64029,235,00428 M to 29.2 M (+4.25 %)
May 25 2016ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP10.042,40024,09628,043,40428 M to 28 M (+0.01 %)

Page:   1